Working in Partnership with Providers

With the integral support of healthcare professionals, Stealth BioTherapeutics is working towards our mission of bringing patients mitochondrial targeted therapies to treat both rare and common diseases. We believe strongly in the potential of our science to deliver new treatment solutions and improve quality of life for patients with diseases involving mitochondrial dysfunction, including diseases for which there are no FDA-approved treatments.

Driven by a desire to help patients with unmet treatment needs, our team collaborates with well-recognized institutions, physicians and scientists to develop the next generation of therapies focusing on mitochondrial dysfunction. Our clinical development program is focused on the pursuit of clinical trials in a variety of diseases involving mitochondrial dysfunction, including primary mitochondrial disease, mitochondrial myopathy, neurodegenerative diseases, dry age-related macular degeneration, certain skeletal muscle disorders and rare inherited diseases.

Resources that Healthcare Professionals may find helpful:

Patients – Read about our commitment to developing treatments for a unique, underserved patient population.
Clinical – Learn more about elamipretide in current clinical trials.
Advisor Portal – Enter the Stealth BioTherapeutics Advisor Portal.